# Thomas Bieber

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/thomas-bieber/

## Facts

| Field | Value |
| --- | --- |
| Citations | 50,125 |
| Field | Dermatology and Skin Diseases |
| h-index | 106 |
| i10-index | 443 |
| Last Known Institution | DB Engineering & Consulting (Germany) |
| OpenAlex ID | https://openalex.org/A5021862730 |
| ORCID iD | 0000-0002-8800-3817 |
| Works | 880 |

## Researcher papers

Showing 12 of 23.

- [Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003](https://scholariq.org/papers/revised-nomenclature-for-allergy-for-global-use-report-of-the-nomenclature/)
- [Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis](https://scholariq.org/papers/two-phase-3-trials-of-dupilumab-versus-placebo-in-atopic-dermatitis/)
- [Atopic Dermatitis](https://scholariq.org/papers/atopic-dermatitis-4/)
- [Atopic dermatitis](https://scholariq.org/papers/atopic-dermatitis-2/)
- [Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis](https://scholariq.org/papers/dupilumab-treatment-in-adults-with-moderate-to-severe-atopic-dermatitis/)
- [Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I](https://scholariq.org/papers/consensus-based-european-guidelines-for-treatment-of-atopic-eczema-atopic/)
- [Atopic dermatitis](https://scholariq.org/papers/atopic-dermatitis-5/)
- [Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report](https://scholariq.org/papers/diagnosis-and-treatment-of-atopic-dermatitis-in-children-and-adults-european/)
- [Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II](https://scholariq.org/papers/consensus-based-european-guidelines-for-treatment-of-atopic-eczema-atopic-2/)
- [Guidelines for treatment of atopic eczema (atopic dermatitis) Part I](https://scholariq.org/papers/guidelines-for-treatment-of-atopic-eczema-atopic-dermatitis-part-i/)
- [Cellular and molecular immunologic mechanisms in patients with atopic dermatitis](https://scholariq.org/papers/cellular-and-molecular-immunologic-mechanisms-in-patients-with-atopic-dermatitis/)
- [Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial](https://scholariq.org/papers/efficacy-and-safety-of-dupilumab-in-adults-with-moderate-to-severe-atopic/)

## Researcher topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Food Allergy and Anaphylaxis Research](https://scholariq.org/topics/food-allergy-and-anaphylaxis-research/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Researcher university

- [DB Engineering & Consulting (Germany)](https://scholariq.org/institutions/db-engineering-and-consulting-germany/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.